Intrexon | XON - Custo de Mercadoria Vendida





Custo de Mercadoria Vendida Alterar Data
Agenus USD 642K 399K 2025-09
Alaunos Therapeutics USD 0 18K 2024-09
Amgen USD 1.87B 271M 2026-06
Anika Therapeutics USD 11.44M 797K 2025-12
AstraZeneca USD 2.52B 2.73B 2026-06
Bristol-Myers Squibb USD 7.89B 4.03B 2026-06
Gilead Sciences USD 1000M 445M 2026-06
GlaxoSmithKline GBP 2.07B 192M 2026-06
Heron Therapeutics USD 11.12M 795K 2025-12
Incyte USD 104.96M 457K 2026-06
Intrexon USD 1.01M 344K 2024-06
Karyopharm Therapeutics USD 1.34M 139K 2026-03
Ligand Pharmaceuticals USD 11.31M 59K 2026-06
MacroGenics USD 9.53M 585K 2026-03
MannKind USD 34.21M 5.38M 2026-06
Merck USD 3.14B 200M 2026-06
Novartis USD 3.71B 251M 2026-06
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Roche Holding CHF 7.85B 630M 2026-06
Sangamo BioSciences 2.42M 1.11M 2024-06
Thermo Fisher Scientific USD 7.54B 577M 2026-06
Veracyte USD 42.19M 3.7M 2026-06
Xencor USD 61.66M 50.95M 2025-06